A 5-hydroxymethylcytosine-based noninvasive model for acute myocardial infarction in type 2 diabetes: implications in cardiovascular outcomes from a 5-year median follow-up study

Key Result

A 5hmC-derived weighted epigenetic score (eSCORE-CARD) was significantly associated with an increased risk of composite cardiovascular outcomes (HR 4.25) in patients with type 2 diabetes.

Key Points

• The research aims to identify specific biomarkers related to acute myocardial infarction in individuals with type 2 diabetes.
• Identified 5-hydroxymethylcytosine (5hmC) signatures in patients with type 2 diabetes.
• Conducted a 5-year follow-up to assess cardiovascular outcomes.
• Developed a risk management tool based on observed biomarkers.
• Found specific 5hmC signatures associated with acute myocardial infarction in type 2 diabetes.
• Demonstrated potential for improved cardiovascular risk management in the diabetic population.